About SCIderm GmbH
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at SCIderm GmbH
During the past decade, SCIderm GmbH conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 6 clinical trials were completed, i.e. on
average, 120% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 4 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Optimal Timing for Performing Loop Electrosurgical Excision Procedure
2019-05-20
2019-09-18
Completed
75
Coffee Consumption for Intestinal Function Recovery After Laparoscopic Gynecologic Surgery
2019-05-27
2019-12-31
Completed
100
Anesthesia on Postoperative Pain After Loop Electrosurgical Excision Procedure
2021-08-09
2022-08-31
Completed
248
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "SCIderm GmbH" #1 sponsor was "LEO Pharma" with 3 trials, followed by "Amgen" with 1 trials
sponsored, "Forward-Pharma GmbH" with 1 trials sponsored, "Janssen Research & Development, LLC" with 1 trials sponsored and "Janssen-Cilag G.m.b.H"
with 1 trials sponsored. Other sponsors include -1 different institutions and
companies that sponsored additional 9 trials in total.
Clinical Trials Conditions at SCIderm GmbH
According to Clinical.Site data, the most researched conditions in "SCIderm GmbH" are
"Psoriasis" (3 trials), "Actinic Keratosis" (2 trials), "Psoriasis Vulgaris" (2 trials), "Atopic Dermatitis" (1 trials) and "Blister" (1 trials). Many other conditions were trialed in "SCIderm GmbH" in a lesser frequency.
Clinical Trials Intervention Types at SCIderm GmbH
Most popular intervention types in "SCIderm GmbH" are "Drug" (9 trials), "Biological" (1 trials), "Device" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials), "Guselkumab" (2 trials), "Apremilast" (1 trials), "Brodalumab" (1 trials) and "Diclofenac" (1 trials). Other intervention names were less common.
Clinical Trials Genders at SCIderm GmbH
The vast majority of trials in "SCIderm GmbH" are
11 trials for "All" genders.
Clinical Trials Status at SCIderm GmbH
Currently, there are NaN active trials in "SCIderm GmbH".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 10 completed trials in SCIderm GmbH,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in SCIderm GmbH, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 7 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 2 trials, and there were
also 1 trials that are defined as “Not Applicable".